EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

LILRB1 enhances the progression of diffuse large B-cell lymphoma through the CREB-SORBS3 pathway

Liyuan Cao, Hanqing Zhao, Xuanyi Zhou, Jin Yuan, Lietao Weng, Zhuo Yu, Junke Zheng, Chiqi Chen

Cellular Oncology · 2025-08 · 48 (4) · 1005-1018

DOI: 10.1007/s13402-025-01060-x ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cellular Oncology, online erschienen am 07.05.2025. Verfasst von Liyuan Cao und 7 weiteren Autor:innen. Beteiligte Einrichtung: Hongqiao International Institute of Medicine, Shanghai Tongren Hospital, Key Laboratory of Cell Differentiation and Apoptosis of Chinese Ministry of …. Hauptthemen laut MEDLINE: Lymphoma, Large B-Cell, Diffuse, Signal Transduction, Disease Progression, Cyclic AMP Response Element-Binding Protein. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Basic Research Program of China, National Natural Science Foundation of China, National Postdoctoral Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lymphoma, Large B-Cell, DiffuseSignal TransductionDisease ProgressionCyclic AMP Response Element-Binding ProteinLeukocyte Immunoglobulin-like Receptor B1HumansCell Line, TumorAnimalsCell ProliferationGene Expression Regulation, NeoplasticMiceFemaleMalePhosphorylation

Stichwörter der Autor:innen

CREBDiffuse large B-cell lymphomaLILRB1ProliferationSORBS3

Substanzen

Cyclic AMP Response Element-Binding ProteinLeukocyte Immunoglobulin-like Receptor B1

Autor:innen und Institutionen

  • Hongqiao International Institute of Medicine, Shanghai Tongren Hospital, Key Laboratory of Cell Differentiation and Apoptosis of Chinese Ministry of Education, Faculty of Basic Medicine, Shanghai Jiao Tong University Sc…
  • School of Integrative Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, China.
  • School of Integrative Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, China. zhengjunke@shsmu.edu.cn.

Förderung

  • National Basic Research Program of China
  • National Natural Science Foundation of China
  • National Postdoctoral Science Foundation of China
  • Shanghai Science and Technology Commission
  • Shanghai Municipal Health Commission

Zitieren

APA

Cao, L., Zhao, H., Zhou, X., Yuan, J., Weng, L., Yu, Z., Zheng, J., & Chen, C. (2025). LILRB1 enhances the progression of diffuse large B-cell lymphoma through the CREB-SORBS3 pathway. Cellular Oncology, 48(4), 1005-1018. https://doi.org/10.1007/s13402-025-01060-x

Vancouver

Cao L, Zhao H, Zhou X, Yuan J, Weng L, Yu Z, et al. LILRB1 enhances the progression of diffuse large B-cell lymphoma through the CREB-SORBS3 pathway. Cellular Oncology. 2025;48(4):1005-1018. doi:10.1007/s13402-025-01060-x

BibTeX
@article{Cao2025,
  author = {Cao, Liyuan and Zhao, Hanqing and Zhou, Xuanyi and Yuan, Jin and Weng, Lietao and Yu, Zhuo and Zheng, Junke and Chen, Chiqi},
  title = {LILRB1 enhances the progression of diffuse large B-cell lymphoma through the CREB-SORBS3 pathway},
  journal = {Cellular Oncology},
  year = {2025},
  volume = {48},
  number = {4},
  pages = {1005--1018},
  doi = {10.1007/s13402-025-01060-x}
}
Kostenlos starten →